Apigenin (0, 10, 25, and 50 μM) activates apoptosis in pancreatic cancer cells by suppressing the GSK-3β/NF-κB signaling pathway (Figure 8) (Johnson and de Mejia, 2013). Here, NFKB1 is linked to pancreatic neoplasm.